These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16254043)

  • 1. Impaired fatty acid utilization in thioredoxin binding protein-2 (TBP-2)-deficient mice: a unique animal model of Reye syndrome.
    Oka S; Liu W; Masutani H; Hirata H; Shinkai Y; Yamada S; Yoshida T; Nakamura H; Yodoi J
    FASEB J; 2006 Jan; 20(1):121-3. PubMed ID: 16254043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thioredoxin binding protein-2 mediates metabolic adaptation in response to lipopolysaccharide in vivo.
    Oka S; Liu W; Yoshihara E; Ahsan MK; Ramos DA; Son A; Okuyama H; Zhang L; Masutani H; Nakamura H; Yodoi J
    Crit Care Med; 2010 Dec; 38(12):2345-51. PubMed ID: 20838331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thioredoxin binding protein-2 inhibits excessive fetal hypoglycemia during maternal starvation by suppressing insulin secretion in mice.
    Mogami H; Yura S; Tatsumi K; Fujii T; Fujita K; Kakui K; Kondoh E; Inoue T; Fujii S; Yodoi J; Konishi I
    Pediatr Res; 2010 Feb; 67(2):138-43. PubMed ID: 19809375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thioredoxin and thioredoxin-binding protein-2 in cancer and metabolic syndrome.
    Kaimul AM; Nakamura H; Masutani H; Yodoi J
    Free Radic Biol Med; 2007 Sep; 43(6):861-8. PubMed ID: 17697931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thioredoxin binding protein-2/thioredoxin-interacting protein is a critical regulator of insulin secretion and peroxisome proliferator-activated receptor function.
    Oka S; Yoshihara E; Bizen-Abe A; Liu W; Watanabe M; Yodoi J; Masutani H
    Endocrinology; 2009 Mar; 150(3):1225-34. PubMed ID: 18974273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The roles of thioredoxin and thioredoxin-binding protein-2 in endometriosis.
    Seo SK; Yang HI; Lee KE; Kim HY; Cho S; Choi YS; Lee BS
    Hum Reprod; 2010 May; 25(5):1251-8. PubMed ID: 20172870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The involvement of thioredoxin and thioredoxin binding protein-2 on cellular proliferation and aging process.
    Yoshida T; Nakamura H; Masutani H; Yodoi J
    Ann N Y Acad Sci; 2005 Dec; 1055():1-12. PubMed ID: 16387713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart-type fatty acid-binding protein reciprocally regulates glucose and fatty acid utilization during exercise.
    Shearer J; Fueger PT; Rottman JN; Bracy DP; Binas B; Wasserman DH
    Am J Physiol Endocrinol Metab; 2005 Feb; 288(2):E292-7. PubMed ID: 15454399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reye syndrome: rate of oxidation of fatty acids in leukocytes and serum levels of lipid peroxides.
    Yoshida Y; Singh I; Singh AK; Tecklenberg FW; Brown FR; Darby CP
    J Exp Pathol; 1989; 4(3):133-9. PubMed ID: 2769452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-oxidative, anti-cancer and anti-inflammatory actions by thioredoxin 1 and thioredoxin-binding protein-2.
    Watanabe R; Nakamura H; Masutani H; Yodoi J
    Pharmacol Ther; 2010 Sep; 127(3):261-70. PubMed ID: 20435060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of human osteoclast differentiation by thioredoxin binding protein-2 and redox-sensitive signaling.
    Aitken CJ; Hodge JM; Nishinaka Y; Vaughan T; Yodoi J; Day CJ; Morrison NA; Nicholson GC
    J Bone Miner Res; 2004 Dec; 19(12):2057-64. PubMed ID: 15537450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thioredoxin-interacting protein (Txnip) is a critical regulator of hepatic glucose production.
    Chutkow WA; Patwari P; Yoshioka J; Lee RT
    J Biol Chem; 2008 Jan; 283(4):2397-406. PubMed ID: 17998203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redox regulation by thioredoxin and thioredoxin-binding proteins.
    Nishiyama A; Masutani H; Nakamura H; Nishinaka Y; Yodoi J
    IUBMB Life; 2001 Jul; 52(1-2):29-33. PubMed ID: 11795589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thioredoxin-binding protein-2-like inducible membrane protein is a novel vitamin D3 and peroxisome proliferator-activated receptor (PPAR)gamma ligand target protein that regulates PPARgamma signaling.
    Oka S; Masutani H; Liu W; Horita H; Wang D; Kizaka-Kondoh S; Yodoi J
    Endocrinology; 2006 Feb; 147(2):733-43. PubMed ID: 16269462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression.
    Nishiyama A; Matsui M; Iwata S; Hirota K; Masutani H; Nakamura H; Takagi Y; Sono H; Gon Y; Yodoi J
    J Biol Chem; 1999 Jul; 274(31):21645-50. PubMed ID: 10419473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of thioredoxin binding protein-2/Txnip in human placenta: Possible involvement of hypoxia in its suppression during early pregnancy.
    Mogami H; Yura S; Kondoh E; Masutani H; Yodoi J; Konishi I
    J Obstet Gynaecol Res; 2017 Jan; 43(1):50-56. PubMed ID: 27762463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PPARgamma agonist induced cardiac enlargement is associated with reduced fatty acid and increased glucose utilization in myocardium of Wistar rats.
    Edgley AJ; Thalén PG; Dahllöf B; Lanne B; Ljung B; Oakes ND
    Eur J Pharmacol; 2006 May; 538(1-3):195-206. PubMed ID: 16674938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition by salicylic acid of the activation and thus oxidation of long chain fatty acids. Possible role in the development of Reye's syndrome.
    Deschamps D; Fisch C; Fromenty B; Berson A; Degott C; Pessayre D
    J Pharmacol Exp Ther; 1991 Nov; 259(2):894-904. PubMed ID: 1941634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cells derived from TBP-2-deficient mice are defective in inducing T cell responses.
    Son A; Nakamura H; Okuyama H; Oka S; Yoshihara E; Liu W; Matsuo Y; Kondo N; Masutani H; Ishii Y; Iyoda T; Inaba K; Yodoi J
    Eur J Immunol; 2008 May; 38(5):1358-67. PubMed ID: 18425727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ursodeoxycholic acid treatment of hepatic steatosis: a (13)C NMR metabolic study.
    Nunes PM; Jones JG; Rolo AP; Palmeira CM; Carvalho RA
    NMR Biomed; 2011 Nov; 24(9):1145-58. PubMed ID: 21538633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.